Yes, a shortage of certain strengths of quetiapine standard release tablets has been identified in 2024.
Current Status of Quetiapine Supply
A confirmed supply issue affects specific strengths of quetiapine standard release tablets in 2024. This situation impacts particular dosage strengths commonly prescribed to patients. It is important for healthcare providers and patients to be aware of these current limitations in availability.
Affected Strengths and Expected Duration
The identified shortage pertains exclusively to the standard release formulations of quetiapine. The specific strengths experiencing limited stock are:
- 150mg standard release tablets
- 200mg standard release tablets
- 300mg standard release tablets
The supply for these particular strengths is expected to remain limited. This shortage is anticipated to continue until at least the end of August 2024.
To summarize the details of the affected formulations and the duration of the supply limitation:
| Quetiapine Formulation | Affected Strengths (Standard Release) | Expected Duration of Limitation |
|---|---|---|
| Standard Release Tablets | 150mg, 200mg, 300mg | Until end of August 2024 |
Impact on Patients
This supply challenge directly affects a notable number of individuals. Information indicates that approximately 652 patients have active prescriptions for the affected strengths of quetiapine. Consequently, patients relying on these specific dosages may encounter difficulties when attempting to fill or refill their prescriptions.
What this means for affected patients:
- Potential for disrupted access: Patients may find it challenging to obtain their prescribed 150mg, 200mg, or 300mg standard release quetiapine tablets.
- Urgent consultation with healthcare providers: It is crucial for any patient affected by this shortage to promptly contact their doctor or pharmacist. Healthcare professionals can offer guidance on managing the situation, which may include:
- Evaluating if an alternative strength, if not affected by the shortage, could be suitable with dosage adjustments.
- Considering other formulations of quetiapine, such as extended-release versions, if clinically appropriate and available, as these are not indicated in the current shortage.
- Discussing potential alternative medications, if necessary, under strict medical supervision.
Navigating Medication Shortages
Medication shortages present significant challenges for both individuals and the healthcare system. In such scenarios, pharmacies and healthcare facilities actively work to manage existing inventory and communicate effectively with patients. Patients are encouraged to maintain proactive communication with their healthcare team regarding their medication needs and to plan refills well in advance whenever possible.
